The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ENLIGHT: Pancancer response prediction to targeted and immunotherapies via tumor transcriptomics.
 
Ranit Aharonov
Employment - Pangaea Biotech
Leadership - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Gal Dinstag
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Eldad Shulman
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Efrat Elis
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Doreen Ben-Zvi
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Omer Tirosh
Employment - Pangaea Biotech
Stock and Other Ownership Interests - Pangaea Biotech
 
Danh-Tai Hoang
No Relationships to Disclose
 
Sanju SInha
No Relationships to Disclose
 
Andrea B. Apolo
No Relationships to Disclose
 
William L. Dahut
Leadership - Dexcom (I)
Stock and Other Ownership Interests - Dexcom (I)
 
Stan Lipkowitz
No Relationships to Disclose
 
Raanan Berger
Stock and Other Ownership Interests - Curesponse; Oncohost; Pangaea Biotech
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; MSD
Research Funding - Bristol-Myers Squibb; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Razelle Kurzrock
Leadership - CureMatch; CureMetrix
Stock and Other Ownership Interests - CureMatch; CureMetrix; IDbyDNA
Honoraria - AACR; Advanced Therapeutics; Bicara Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; Foundation Medicine; LEK; Merck; Meyer Consulting; NeoGenomics Laboratories; NeoMed; Pfizer; Roche; Turning Point Therapeutics; Wiley
Consulting or Advisory Role - Actuate Therapeutics; AstraZeneca; Bicara Therapeutics; Biological Dynamics; Daiichi Sankyo; Eisai; EOM Pharmaceuticals; Gaido; Iylon; Loxo; Merck; NeoMed; Pfizer; Prosperdtx; Roche; Soluventis; TD2/Volastra; Turning Point Therapeutics; XBiotech
Speakers' Bureau - Roche
Research Funding - Biological Dynamics (Inst); Boehringer Ingelheim (Inst); Debiopharm Group (Inst); Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); MedImmune (Inst); Merck Serono (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst); Takeda (Inst); Top Alliance BioScience (Inst)
Travel, Accommodations, Expenses - AACR; Advanced Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; LEK; NeoGenomics Laboratories; NeoMed; Roche; Wiley
 
Antonios Papanicolau-Sengos
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose
 
Padma Sheila Rajagopal
No Relationships to Disclose
 
Mark R. Gilbert
No Relationships to Disclose
 
Kenneth D. Aldape
No Relationships to Disclose
 
Tuvik Beker
Employment - Pangaea Biotech
Leadership - MedAware; Pangaea Biotech
Stock and Other Ownership Interests - MedAware; Pangaea Biotech
Patents, Royalties, Other Intellectual Property - Patents and pending patents assigned to MedAware and Pangea
 
Eytan Ruppin
Stock and Other Ownership Interests - MedAware; Metabomed
Patents, Royalties, Other Intellectual Property - Patent applications have been submitted by Te-Aviv University, U Maryland and NCI for synthetic lethality and expression deconvolution computational analysis approaches
(OPTIONAL) Uncompensated Relationships - Pangea